COVID-19 Weekly Update - Tuesday March 14, 2023 Tags COVID-19 Daily Update Read more about COVID-19 Weekly Update - Tuesday March 14, 2023Log in to post comments
Media Release: Voluntary recall of Apotex Corporation Brimonidine Tartrate Ophthalmic Solution 0.15% and Pharmedica Purely Soothing, 15% MSM Drops Tags News Read more about Media Release: Voluntary recall of Apotex Corporation Brimonidine Tartrate Ophthalmic Solution 0.15% and Pharmedica Purely Soothing, 15% MSM DropsLog in to post comments
International Women's Day Message from the Ministry of Health Tags News Read more about International Women's Day Message from the Ministry of HealthLog in to post comments
COVID-19 Weekly Update - Tuesday March 07, 2023 Tags COVID-19 Daily Update Read more about COVID-19 Weekly Update - Tuesday March 07, 2023Log in to post comments
Screening Locations for International Women's Day 2023 Read more about Screening Locations for International Women's Day 2023Log in to post comments
COVID-19 Weekly Update - Tuesday February 28, 2023 Tags COVID-19 Daily Update Read more about COVID-19 Weekly Update - Tuesday February 28, 2023Log in to post comments
Media Release - Reckitt Recalls 145,000 Cans of Enfamil ProSobee Simply Plant-Based Infant Formula Tags News Read more about Media Release - Reckitt Recalls 145,000 Cans of Enfamil ProSobee Simply Plant-Based Infant FormulaLog in to post comments
COVID-19 Weekly Update - Tuesday February 21, 2023 Tags COVID-19 Daily Update Read more about COVID-19 Weekly Update - Tuesday February 21, 2023Log in to post comments
Media Release - Sun Pharma Voluntary Recall of Diltiazem Hydrochloride Extended Release Capsules 360mg for High Blood Pressure Tags News Read more about Media Release - Sun Pharma Voluntary Recall of Diltiazem Hydrochloride Extended Release Capsules 360mg for High Blood PressureLog in to post comments
Media Release - COVID-19 Prevention, Detection and System Response Tags News Read more about Media Release - COVID-19 Prevention, Detection and System ResponseLog in to post comments
